Published

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: University of Groningen research database (University of Groningen / Centre for Information Technology)
Date: 2026-06-29
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Stefanie Enriquez Geppert Lisa Bevers Arvid Rosander Peter Fodran Vince Polito

Watch author

Derived topics and classifications

psilocybin Clinical Trial Safety Toxicity Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care PatientsJournal of Health Service Psychology · 2025-12-01 Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?Journal of Humanistic Psychology · 2025-03-21 Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-02-01 Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)Current Psychology · 2024-11-21 Psychedelic Drug Therapy for Mental Disorders?Open Journal of Medical Psychology · 2023-01-01 A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16 Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of AlcoholismJournal of Humanistic Psychology · 2016-10-16 Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military PersonnelJournal of Police and Criminal Psychology · 2026-03-22